For those who understand Multiple Myeloma and are following Hamada’s clinical details the M-Spike(PP) is now a whopping 18.1 !! the higher this reading goes the more damage will be done to Hamada’s bones and vital organs which is the nature of this disease.
Hamada is to have another bone marrow aspiration (5th one in all) and a further X-Ray on his back and pelvis next Monday then on the 15th February the consultant will discuss at a meeting with other Haematology Doctors and Prof Russell from the Clinical Haematology Centre at Nottingham, with the view to Hamada starting Velcade which is a newer chemotherapy drug and one Hamada has not tried before and is allowed here on the NHS for first relapse. This is not an easy decision to arrive at and must be weighed carefully against Hamada’s poor blood counts and his quality of life now but as MM rears it’s ugly head once more, the feeling is we must wage war with further Chemotherapy.
So really sorry to hear of this and hope that the problem is sorted with the new treatment. My very best wishes to Hamada…
I’m so sorry the numbers weren’t what we hoped for, Susie. Velcade (along with Doxil) gave Vern a 2 year remission. He went back on it in 2009 when the beast returned, but is doing it just once a week instead of normal protocol – and it brought his numbers down. Is on hold during these 8 weeks of heavy antibiotics; hoping numbers will hold steady until he can get back on it. I do understand the concern about QOL … it’s such a difficult decision. My fond wishes to you both.
It’s really a nice and helpful piece of information. I’m glad that you shared this helpful info with us. Please keep us informed like this. Thanks for sharing.
i impart with subsistence to ones mind it Today’s visit to Haematology at Lincoln — susiehemingway.com since im your rss reader